Physician profile
Vini Bapna
NPI 1912116708
$1,487.78
in general payments reported to CMS, 2019-2025
23 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $240 · 2021: $261 · 2023: $166 · 2024: $299 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $291.93 | 2019-2025 | Freestyle Libre 3, Eterna |
| Astrazeneca Pharmaceuticals LP | $263.03 | 2019-2024 | Breztri |
| Glaxosmithkline, LLC. | $148.44 | 2019-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $147.00 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $141.81 | 2020-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.09 | 2021-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $46.23 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $41.63 | 2021 | |
| Exact Sciences Corporation | $39.00 | 2024-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $37.48 | 2019 | |
| Pfizer INC. | $36.78 | 2023-2024 | |
| Arbor Pharmaceuticals, INC. | $27.14 | 2019 | |
| Dexcom, INC. | $25.15 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $21.14 | 2024 | Venaseal |
| Itamar Medical INC | $19.15 | 2024 | Watchpatone |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $18.96 | 2023 | Bd Affirm Vpiii Microbial Identification Test |
| Regeneron Healthcare Solutions, INC. | $18.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.32 | 2023 | Xarelto |
| Phadia US INC. | $15.72 | 2023 | Immunocap |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.57 | 2024 | Xifaxan |
| Renalytix Ai, INC. | $15.21 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Nestle Healthcare Nutrition INC. | $14.70 | 2021 | |
| Tactile Systems Technology INC | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vini Bapna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.